The Emerging Role of 5-Fluorouracil and Leucovorin in the Treatment of Advanced Breast Cancer. A Review-Reference-Cited by-同舟云学术

The Emerging Role of 5-Fluorouracil and Leucovorin in the Treatment of Advanced Breast Cancer. A Review

Published:1989-10 Issue:5 Volume:1 Page:330-337
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Zaniboni A.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference34 articles.

1. Garewal HS. Mitomycin C in the chemotherapy of advanced breast cancer. Semin Oncol 1988; 15: 74–9.

2. Henderson IC, Hayes DF, Come S. New medical treatments for advanced breast cancer. Semin Oncol 1987; 14: 34-64.

3. Hoogstraten B, Fabian C. A reappraisal of single drugs in advanced breast cancer. Cancer Clin Trials 1979; 2: 101–9.

4. Rustum YM. Selective modulation of 5-Fluorouracil action in patients with colorectal carcinoma. Chemioterapia 1985; 4: 377–82.

5. Yin MB, Zakrewski SF, Hakala MT et al. Relationship of cellular folate cofactor pools to the activity of 5-Fluorouracil. Molec Pharmacol 1983; 23: 190–7.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vesicular IFN-γ as a cooperative attacker to enhance anti-cancer effect of 5-fluorouracil via thymidine phosphorylase upregulation and tumor microenvironment normalization;Nanomedicine: Nanotechnology, Biology and Medicine;2022-02

2. Uridine phosphorylase in biomedical, structural, and functional aspects: A review;Crystallography Reports;2011-07

3. Mitoxantrone, L-Leucovorin and 5-Fluorouracil: An Effective and Well Tolerated First-Line Treatment for Advanced Breast Cancer;Tumori Journal;1999-01

4. Treatment of Previously Treated Metastatic Breast Cancer by Mitoxantrone and 48-Hour Continuous Infusion of High-dose 5-FU and Leucovorin (MFL): Low Palliative Benefit and High Treatment-Related Toxicity;Japanese Journal of Clinical Oncology;1997-10-01

5. Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients;Breast Cancer Research and Treatment;1996-02